Home
- Investor Relations
Siemens Healthineers AG
Investor Relations
First-hand information for our shareholders and the capital market
Second-quarter results FY2024 | May 7, 2024
Reports & presentations
Second-quarter results FY2024 | May 7, 2024
Analyst call recording
(Audio webcast)
Presentation(pdf, 858.12 KB)
Quarterly statement(pdf, 283.90 KB)
Half-year financial report Q2 FY2024(pdf, 343.53 KB)
Pre Q2 FY2024 Consensus for FY2024 - FY2026 – April 25, 2024(xlsx, 28.62 KB)
Press
Investor feedback
You will be redirected to QuantiFire. QuantiFire performs this survey in own controllership. The privacy policy* of QuantiFire can be found at the end of this page.
Sustainability
<p><strong>We pioneer breakthroughs in healthcare. </strong><strong>For everyone. Everywhere. Sustainably.</strong><br><br>The world’s resources are limited; our collective challenges are urgent. At Siemens Healthineers, we want to advance a world where breakthroughs in healthcare create new possibilities with a minimal impact on our planet. As a leading MedTech company we are uniquely positioned to solve healthcare challenges through our technologies and innovative solutions.</p>
Contact for private investors
<a href="mailto:ir.team@siemens-healthineers.com"> ir.team@siemens-healthineers.com</a>
Contact for institutional investors and analysts
Marc Koebernick
Head of Investor Relations
Dr. Carlo Beck
Continental Europe & Nordics
Hans-Christian Jessen
United States & Canada (US based)
Dr. Kristina Kilian
Corporate Governance & ESG
Efsun Kece Sarac
Targeting, Roadshows and Events
Sebastian Weiss
UK, Ireland & Benelux